Spark Therapeutics Inc.

(ONCE) Trade

By |

Profile

Spark Therapeutics Inc is a gene therapy company. The Company is engaged in developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.

Contact Information

Website: www.sparktx.com
Email: investor@sparktx.com
Main Phone: +1 888 772-7560
Address: 3737 Market Street
Address 2: Suite 1300
State: PA
City / Town: Philadelphia
Country: USA
Postal Code: 19104

Issuer Information

Exchange: NGS
CEO: Jeffrey D. Marrazzo
Employees: 315
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 82.44 $ 1.19 (1.46%)
Last Price 82.44 Change $ 1.19 Change % 1.46 Tick N/A
Bid 82.14 Bid Size 200.00 Ask 82.44 Ask Size 100.00
Open 81.33 High 83.40 Low 81.33 Prev Close 81.25
Last Trade Volume 27,590 52 Wk Hi 96.59 52 Wk Low 41.06
Market Cap 3.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 37,386,347.00 EPS (TTM) -7.29 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 14 103
Number of Buys 10 48
Number of Sells 4 55
Net Activity 9000 -140996
Last 10 Buys Shares
John Furey 1,000
Elliott Sigal 1,000
Steven M. Altschuler 1,000
Elliott Sigal 1,000
Stephen W. Webster 1,000
Rogerio Coelho Vivaldi 1,000
Katherine A. High 1,000
Anand Mehra 1,000
Last 10 Sell Shares
John Furey 1,000
John Furey 1,000
John Furey 1,000
John Furey 1,000
John Furey 1,000
Katherine A. High 1,000
Elliott Sigal 1,000
Katherine A. High 1,000
Stephen W. Webster 1,000
Jeffrey D. Marrazzo 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 103 103 103 103
Low Target Price Estimate 40 40 40 40
Mean Target Price Estimate 78.22 78.22 78.22 78.22
Standard Deviation 15.63 15.63 15.63 15.63
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 06/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 10 11 11
Moderate Buy 2 2 2 2
Hold 6 6 4 4
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.95 1.95 1.78 1.78